top of page
Investor Material
Top
Webcasts
Video
Corporate Publications
Webcast
WEBCASTS
Anavex Life Sciences Reports Fiscal 2023 First Quarter Financial Results
Anavex Life Sciences Presents at the 41st Annual J.P. Morgan Healthcare Conference
Anavex Life Sciences to Announce Management Webcast and Conference Call
Anavex Life Sciences Reports Fiscal 2022 Year End Financial Results and Provides Business Update
Anavex Life Sciences to Present at the Guggenheim 4th Annual Immunology and Neurology Conference 2022
Anavex Life Sciences Reports Third Quarter Financial Results and Business Update
Anavex Life Sciences Presents at the H. C. Wainwright Global Investment Conference 2022
Anavex Life Sciences Reports Second Quarter Financials and Business Outlook 2022
Annual Needham Virtual Neuroscience Forum 2022
Anavex Life Sciences Reports First Quarter Financials and Business Outlook 2022
ANAVEX®2-73 AVATAR Phase 3 Trial met Primary and Secondary Efficacy Endpoints
2nd Annual Mitochondria-Targeted Drug Development - February 24, 2022
ANAVEX®3-71 Phase 1 Top Line Data Conference Call
40th Annual J.P. Morgan Healthcare Conference
4th Annual Evercore ISI HealthCONx Conference
Anavex Life Sciences Reports Fourth Quarter Financials and Business Outlook 2021
Anavex Life Sciences Reports Third Quarter Financials and Business Outlook 2021
Anavex Life Sciences Reports Second Quarter Financials and Business Outlook 2021
Anavex Life Sciences Reports First Quarter Financials and Business Outlook 2021
B. Riley Neuroscience Conference April 2021
VIDEO
Video
Educational Video News Release: Broad SIGMAR1 Platform June 2022
Anavex Rett Syndrome Advocacy December 2020
CORPORATE PUBLICATION
Corporate Publications
Corporate Presentation from JPM 2023
2021 Anavex Proxy Statement
Anavex Life Sciences Corp 10K
Anavex Life Sciences Corp 10Q for Q2 2022
Anavex Life Sciences Corp 10Q for Q3 2022
CTAD Presentation November 2020
Stay Connected
Follow us on social media
Events
Newsroom
Contact Us
bottom of page
